Endospan Enrolls First Patient in the TRIOMPHE IDE Study Sentara Norfolk General Hospital, Virginia, Implants First TRIOMPHE Study Patient With the NEXUS Aortic Arch Stent Graft System for Minimally Invasive Arch Repair as Part of TRIOMPHE IDE Study Endospan, a pioneer in off-the-shelf endovascular repair of aortic arch disease, announces the first implant of the NEXUS Aortic Arch Stent Graft System on a patient with a thoracic aortic aneurysm as part of the TRIOMPHE Study in Norfolk, Virginia, January 11, 2021. The TRIOMPHE Study is a multi-arm, multi-center, non-randomized, prospective, clinical study to evaluate the safety and effectiveness of NEXUS in treating thoracic aortic lesions involving the aortic arch. The study will enroll 100 patients at up to 30 sites.